Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$205,683,445
+$19,730,604 QoQ
Shares Held
809,873
+6.5% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
1.35%
of 13F equity value
Holder Rank
#198
of 4,663 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026&PARTNERS holds $840,453,680 across 15 Drug Manufacturers - General names. JNJ ranks #2 (24.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
180,745 | $216,790,993 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
809,873 | $205,683,445 | |
| 3 | ABBV |
AbbVie Inc.
|
425,683 | $107,118,870 | |
| 4 | AMGN |
Amgen Inc
|
280,838 | $101,697,056 | |
| 5 | MRK |
Merck & Co., Inc.
|
562,388 | $72,266,858 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
403,145 | $50,933,339 | |
| 7 | NVS |
Novartis AG
|
147,424 | $23,104,289 | |
| 8 | AZN |
Astrazeneca PLC
|
99,983 | $18,958,776 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $205,683,445 | 809,873 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $185,952,841 | 760,730 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $158,046,473 | 763,694 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $122,984,635 | 663,276 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $92,376,784 | 604,758 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $77,832,858 | 469,325 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $61,477,094 | 425,094 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $40,901,351 | 252,384 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,806,353 | 114,986 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $5,052,904 | 31,942 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $3,305,019 | 21,086 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $2,193,894 | 14,086 | Shares | Sole | 2023-10-06 | |
| 2023-06-30 | $2,279,706 | 13,773 | Shares | Sole | 2023-07-05 | |
| 2023-03-31 | $2,100,095 | 13,549 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $2,392,547 | 13,544 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $2,233,948 | 13,675 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $2,344,197 | 13,206 | Shares | Sole | 2022-07-06 | |
| 2021-12-31 | $1,112,126 | 6,501 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $1,060,409 | 6,566 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,053,018 | 6,392 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $1,032,939 | 6,285 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $901,472 | 5,728 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $820,328 | 5,510 | Shares | Sole | 2020-10-05 | |
| 2020-06-30 | $720,728 | 5,125 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $663,255 | 5,058 | Shares | Sole | 2020-04-03 | |
| No filing history on record for this holder in this stock. | ||||||